ECHOSTAR CORP-A (SATS) Fundamental Analysis & Valuation

NASDAQ:SATS • US2787681061

108.5 USD
-2.35 (-2.12%)
Last: Mar 6, 2026, 09:52 AM

This SATS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SATS. SATS was compared to 91 industry peers in the Media industry. SATS may be in some trouble as it scores bad on both profitability and health. SATS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. SATS Profitability Analysis

1.1 Basic Checks

  • SATS had positive earnings in the past year.
  • SATS had a negative operating cash flow in the past year.
  • In multiple years SATS reported negative net income over the last 5 years.
  • Of the past 5 years SATS 4 years had a positive operating cash flow.
SATS Yearly Net Income VS EBIT VS OCF VS FCFSATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B

1.2 Ratios

  • The Return On Assets of SATS (-33.70%) is worse than 74.73% of its industry peers.
  • Looking at the Return On Equity, with a value of -251.43%, SATS is doing worse than 79.12% of the companies in the same industry.
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROIC N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
SATS Yearly ROA, ROE, ROICSATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • Looking at the Gross Margin, with a value of 25.82%, SATS is doing worse than 68.13% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SATS has declined.
  • SATS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
SATS Yearly Profit, Operating, Gross MarginsSATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

0

2. SATS Health Analysis

2.1 Basic Checks

  • SATS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SATS has been increased compared to 1 year ago.
  • Compared to 5 years ago, SATS has more shares outstanding
  • Compared to 1 year ago, SATS has a worse debt to assets ratio.
SATS Yearly Shares OutstandingSATS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SATS Yearly Total Debt VS Total AssetsSATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • SATS has an Altman-Z score of 0.56. This is a bad value and indicates that SATS is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.56, SATS is in line with its industry, outperforming 43.96% of the companies in the same industry.
  • A Debt/Equity ratio of 3.24 is on the high side and indicates that SATS has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 3.24, SATS is doing worse than 74.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACCN/A
WACC7.12%
SATS Yearly LT Debt VS Equity VS FCFSATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • SATS has a Current Ratio of 0.42. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SATS has a worse Current ratio (0.42) than 80.22% of its industry peers.
  • SATS has a Quick Ratio of 0.42. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SATS has a Quick ratio of 0.38. This is amonst the worse of the industry: SATS underperforms 82.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.38
SATS Yearly Current Assets VS Current LiabilitesSATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

4

3. SATS Growth Analysis

3.1 Past

  • SATS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2333.33%, which is quite impressive.
  • SATS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 69.06% yearly.
  • The Revenue has decreased by -5.18% in the past year.
  • Measured over the past years, SATS shows a very strong growth in Revenue. The Revenue has been growing by 51.37% on average per year.
EPS 1Y (TTM)2333.33%
EPS 3Y69.06%
EPS 5YN/A
EPS Q2Q%-183.74%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%

3.2 Future

  • SATS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -15.58% yearly.
  • SATS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.25% yearly.
EPS Next Y-136.68%
EPS Next 2Y-51.4%
EPS Next 3Y-54.55%
EPS Next 5Y-15.58%
Revenue Next Year-2.6%
Revenue Next 2Y-2.01%
Revenue Next 3Y-1.09%
Revenue Next 5Y-0.25%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SATS Yearly Revenue VS EstimatesSATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
SATS Yearly EPS VS EstimatesSATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 -10 -20 -30 -40

2

4. SATS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.80, the valuation of SATS can be described as very reasonable.
  • 80.22% of the companies in the same industry are more expensive than SATS, based on the Price/Earnings ratio.
  • SATS is valuated cheaply when we compare the Price/Earnings ratio to 26.69, which is the current average of the S&P500 Index.
  • The Forward Price/Earnings Ratio is negative for SATS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 10.8
Fwd PE N/A
SATS Price Earnings VS Forward Price EarningsSATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • SATS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SATS is more expensive than 60.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 36.01
SATS Per share dataSATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • SATS's earnings are expected to decrease with -54.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.4%
EPS Next 3Y-54.55%

0

5. SATS Dividend Analysis

5.1 Amount

  • SATS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SATS Fundamentals: All Metrics, Ratios and Statistics

ECHOSTAR CORP-A

NASDAQ:SATS (3/6/2026, 9:52:08 AM)

108.5

-2.35 (-2.12%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-02
Earnings (Next)05-07
Inst Owners95.35%
Inst Owner Change-9.05%
Ins Owners11.95%
Ins Owner Change1.13%
Market Cap31.23B
Revenue(TTM)15.00B
Net Income(TTM)-14.50B
Analysts74.29
Price Target118.22 (8.96%)
Short Float %22.56%
Short Ratio5.68
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)552.23%
Min EPS beat(2)-38.14%
Max EPS beat(2)1142.6%
EPS beat(4)2
Avg EPS beat(4)280.37%
Min EPS beat(4)-38.14%
Max EPS beat(4)1142.6%
EPS beat(8)3
Avg EPS beat(8)141.35%
EPS beat(12)6
Avg EPS beat(12)55.86%
EPS beat(16)8
Avg EPS beat(16)55.46%
Revenue beat(2)0
Avg Revenue beat(2)-3.28%
Min Revenue beat(2)-5.46%
Max Revenue beat(2)-1.09%
Revenue beat(4)0
Avg Revenue beat(4)-3.22%
Min Revenue beat(4)-5.46%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-2.77%
Revenue beat(12)1
Avg Revenue beat(12)-3.2%
Revenue beat(16)4
Avg Revenue beat(16)-2.11%
PT rev (1m)-2.6%
PT rev (3m)58.05%
EPS NQ rev (1m)-9.56%
EPS NQ rev (3m)52.75%
EPS NY rev (1m)1.52%
EPS NY rev (3m)-844.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.6%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-1.26%
Valuation
Industry RankSector Rank
PE 10.8
Fwd PE N/A
P/S 2.08
P/FCF N/A
P/OCF N/A
P/B 5.42
P/tB 5.47
EV/EBITDA 36.01
EPS(TTM)10.05
EY9.26%
EPS(NY)-3.69
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS52.12
BVpS20.03
TBVpS19.84
PEG (NY)N/A
PEG (5Y)N/A
Graham Number67.3
Profitability
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.82%
FCFM N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
F-Score3
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Debt/EBITDA 12.49
Cap/Depr 60.91%
Cap/Sales 6.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.38
Altman-Z 0.56
F-Score3
WACC7.12%
ROIC/WACCN/A
Cap/Depr(3y)111.73%
Cap/Depr(5y)101.51%
Cap/Sales(3y)11.48%
Cap/Sales(5y)15.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2333.33%
EPS 3Y69.06%
EPS 5YN/A
EPS Q2Q%-183.74%
EPS Next Y-136.68%
EPS Next 2Y-51.4%
EPS Next 3Y-54.55%
EPS Next 5Y-15.58%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%
Revenue Next Year-2.6%
Revenue Next 2Y-2.01%
Revenue Next 3Y-1.09%
Revenue Next 5Y-0.25%
EBIT growth 1Y70.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.85%
EBIT Next 3Y32%
EBIT Next 5Y18.28%
FCF growth 1Y-263.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.93%
OCF growth 3YN/A
OCF growth 5YN/A

ECHOSTAR CORP-A / SATS FAQ

Can you provide the ChartMill fundamental rating for ECHOSTAR CORP-A?

ChartMill assigns a fundamental rating of 1 / 10 to SATS.


What is the valuation status of ECHOSTAR CORP-A (SATS) stock?

ChartMill assigns a valuation rating of 2 / 10 to ECHOSTAR CORP-A (SATS). This can be considered as Overvalued.


How profitable is ECHOSTAR CORP-A (SATS) stock?

ECHOSTAR CORP-A (SATS) has a profitability rating of 1 / 10.


Can you provide the financial health for SATS stock?

The financial health rating of ECHOSTAR CORP-A (SATS) is 0 / 10.